|Dr. Richard A. B. Stewart||Chairman & CEO||772.64k||N/A||1959|
|Dr. Anthony Clarke||Pres, Chief Scientific Officer & Director||603.22k||N/A||1956|
|Mr. John A. Bencich||Exec. VP, CFO & COO||539.31k||N/A||1977|
|Dr. Cindy Jacobs||Exec. VP & Chief Medical Officer||593.5k||N/A||1958|
|Ms. Jaime Xinos||Exec. VP of Commercial||N/A||N/A||N/A|
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.